… including fluorescence in situ hybridisation (FISH) and molecular testing and monitoring were
… This seems consistent with case reports of patients with CLL who have achieved remission …

… remission within the first month of treatment. Retrospective fluorescence in situ hybridization
(… Therefore, it was of importance to monitor JAK2 mutation status and evolution of platelet …

… treatment response monitoring of chronic myeloid leukemia. … by gradual but persistent
deterioration in clinical status and … treatment after they achieve a complete cytogenetic remission; …

… achieving treatment-free remission after targeted therapies, … the Ph chromosome by
fluorescence in situ hybridization (FISH) … the involvement of immune cells for the control of TFR. It …

… In molecular cytogenetics, the fluorescence in situ hybridization (FISH) … long-term remission.
Cytogenetic and molecular tests, however, are crucial in the diagnosis of CML, monitoring …

… carry BCR–ABL1 as detected by either fluorescence in situ hybridization (FISH) or reverse
… these two groups consistent with their CML status and clinical presentation. No significant …

… ELN recommendations for monitoring of mutant NPM1 … between MRD status and benefit
from allo-HSCT in first remission. … Nevertheless, this study suggests that MRD status may be a …

… in the recurrence of chronic myeloid leukemia (CML) after the … that in patients who achieved
molecular remission, almost all … DNA obtained at diagnosis served as a positive control and …

… Ph chromosome itself, so fluorescent in situ hybridization (FISH), … response (MR) are
monitored via the reverse transcription … , 12 were in a state of null remission (MRI), with a range of …

… 49 Philadelphia positive chronic myeloid leukaemia patients and … genes amplification by
fluorescence in situ hybridization. … of remission of CML patients after 6-month monitoring period …